ESOPJun 1, 2026, 10:16 AM
AstraZeneca admits 14,120 shares to LSE for employee schemes
AI Summary
AstraZeneca PLC announced the admission of 14,120 new ordinary shares of $0.25 each to trading on the Main Market of the London Stock Exchange. These shares were issued between May 1, 2026, and May 31, 2026, under the company's existing block admission for employee share schemes. Following this admission, the total number of ordinary shares in issue for AstraZeneca PLC is 1,551,009,750.
Key Highlights
- AstraZeneca admitted 14,120 new ordinary shares of $0.25 each to trading.
- The shares were admitted to the Main Market of the London Stock Exchange.
- Total number of ordinary shares in issue following admission is 1,551,009,750.
- The admission is for shares issued under the Company's employee share schemes.
- Shares were issued between May 1, 2026, and May 31, 2026.
- The new shares are fully fungible with existing Ordinary Shares.
Price Impact
More from AZN